API
< Back to all clusters
[HEALTH] · United States · 2 sources

started · updated

FDA-approved drugs show potential to rebuild alveolar bone in diabetic mice

Researchers from the University of Indiana in Indianapolis and the University of Arkansas for Medical Sciences in Little Rock have found that two FDA-approved drugs, parathyroid hormone (PTH) and abaloparatide (ABL), can help rebuild alveolar bone in mice with type 2 diabetes.

Diabetes is known to worsen bone health, specifically increasing the loss of bone tissue around teeth, which can lead to tooth loss. While previous preclinical tests suggested PTH and its analogs could support periodontal healing, this new study published in the International Journal of Oral Science investigated their effectiveness in mice with developed type 2 diabetes.

In mice without diabetes, PTH and ABL stimulated both bone formation and resorption, resulting in no net change in bone mass. However, in diabetic mice, these substances significantly increased bone volume and restored bone height to levels observed in healthy animals. The study identified that the drugs interact with osteocytes and periodontal ligament cells, mapping the biochemical signaling pathway and key receptor involved in this regenerative process.

Entities

International Journal of Oral Science · U.S. Food and Drug Administration · University of Arkansas for Medical Sciences · University of Indiana